Effects of cerebrospinal fluid proteins on brain atrophy rates in cognitively healthy older adults

Niklas Mattsson, Philip Insel, Rachel Nosheny, John Q. Trojanowski, Leslie M. Shaw, Clifford R Jr. Jack, Duygu Tosun, Michael Weiner

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Biomarkers associated with Alzheimer's disease (AD)-like brain atrophy in healthy individuals may identify mechanisms involved in early stage AD. Aside from cerebrospinal fluid (CSF) β-amyloid42 (Aβ42) and tau, no studies have tested associations between CSF proteins and AD-like brain atrophy. We studied 90 healthy elders, who underwent lumbar puncture at baseline, and serial magnetic resonance imaging scans for up to 4 years. We tested statistical effects of baseline CSF proteins (N= 70 proteins related to Aβ42-metabolism, microglial activity, and synaptic/neuronal function) on atrophy rates in 7 AD-related regions. Besides the effects of Aβ42 and phosphorylated tau (P-tau) that were seen in several regions, novel CSF proteins were found to have effects in inferior and middle temporal cortex (including apolipoprotein CIII, apolipoprotein D, and apolipoprotein H). Several proteins (including S100β and matrix metalloproteinase-3) had effects that depended on the presence of brain Aβ pathology, as measured by CSF Aβ42. Other proteins (including P-tau and apolipoprotein D) had effects even after adjusting for CSF Aβ42. The statistical effects in this exploratory study were mild and not significant after correction for multiple comparisons, but some of the identified proteins may be associated with brain atrophy in healthy persons. Proteins interacting with CSF Aβ42 may be related to Aβ brain pathology, whereas proteins associated with atrophy even after adjusting for CSF Aβ42 may be related to Aβ-independent mechanisms.

Original languageEnglish (US)
Pages (from-to)614-622
Number of pages9
JournalNeurobiology of Aging
Volume35
Issue number3
DOIs
StatePublished - Mar 2014

Fingerprint

Cerebrospinal Fluid Proteins
Atrophy
Cerebrospinal Fluid
Apolipoproteins D
Brain
Alzheimer Disease
Proteins
beta 2-Glycoprotein I
Apolipoprotein C-III
Pathology
Matrix Metalloproteinase 3
Spinal Puncture
S100 Proteins
Temporal Lobe
Biomarkers
Magnetic Resonance Imaging

Keywords

  • Alzheimer's disease
  • Atrophy
  • Biomarkers
  • Cerebrospinal fluid
  • Longitudinal

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)
  • Aging
  • Developmental Biology
  • Geriatrics and Gerontology

Cite this

Effects of cerebrospinal fluid proteins on brain atrophy rates in cognitively healthy older adults. / Mattsson, Niklas; Insel, Philip; Nosheny, Rachel; Trojanowski, John Q.; Shaw, Leslie M.; Jack, Clifford R Jr.; Tosun, Duygu; Weiner, Michael.

In: Neurobiology of Aging, Vol. 35, No. 3, 03.2014, p. 614-622.

Research output: Contribution to journalArticle

Mattsson, N, Insel, P, Nosheny, R, Trojanowski, JQ, Shaw, LM, Jack, CRJ, Tosun, D & Weiner, M 2014, 'Effects of cerebrospinal fluid proteins on brain atrophy rates in cognitively healthy older adults', Neurobiology of Aging, vol. 35, no. 3, pp. 614-622. https://doi.org/10.1016/j.neurobiolaging.2013.08.027
Mattsson, Niklas ; Insel, Philip ; Nosheny, Rachel ; Trojanowski, John Q. ; Shaw, Leslie M. ; Jack, Clifford R Jr. ; Tosun, Duygu ; Weiner, Michael. / Effects of cerebrospinal fluid proteins on brain atrophy rates in cognitively healthy older adults. In: Neurobiology of Aging. 2014 ; Vol. 35, No. 3. pp. 614-622.
@article{6c78b496a8da4aca8c5523909b1f6714,
title = "Effects of cerebrospinal fluid proteins on brain atrophy rates in cognitively healthy older adults",
abstract = "Biomarkers associated with Alzheimer's disease (AD)-like brain atrophy in healthy individuals may identify mechanisms involved in early stage AD. Aside from cerebrospinal fluid (CSF) β-amyloid42 (Aβ42) and tau, no studies have tested associations between CSF proteins and AD-like brain atrophy. We studied 90 healthy elders, who underwent lumbar puncture at baseline, and serial magnetic resonance imaging scans for up to 4 years. We tested statistical effects of baseline CSF proteins (N= 70 proteins related to Aβ42-metabolism, microglial activity, and synaptic/neuronal function) on atrophy rates in 7 AD-related regions. Besides the effects of Aβ42 and phosphorylated tau (P-tau) that were seen in several regions, novel CSF proteins were found to have effects in inferior and middle temporal cortex (including apolipoprotein CIII, apolipoprotein D, and apolipoprotein H). Several proteins (including S100β and matrix metalloproteinase-3) had effects that depended on the presence of brain Aβ pathology, as measured by CSF Aβ42. Other proteins (including P-tau and apolipoprotein D) had effects even after adjusting for CSF Aβ42. The statistical effects in this exploratory study were mild and not significant after correction for multiple comparisons, but some of the identified proteins may be associated with brain atrophy in healthy persons. Proteins interacting with CSF Aβ42 may be related to Aβ brain pathology, whereas proteins associated with atrophy even after adjusting for CSF Aβ42 may be related to Aβ-independent mechanisms.",
keywords = "Alzheimer's disease, Atrophy, Biomarkers, Cerebrospinal fluid, Longitudinal",
author = "Niklas Mattsson and Philip Insel and Rachel Nosheny and Trojanowski, {John Q.} and Shaw, {Leslie M.} and Jack, {Clifford R Jr.} and Duygu Tosun and Michael Weiner",
year = "2014",
month = "3",
doi = "10.1016/j.neurobiolaging.2013.08.027",
language = "English (US)",
volume = "35",
pages = "614--622",
journal = "Neurobiology of Aging",
issn = "0197-4580",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Effects of cerebrospinal fluid proteins on brain atrophy rates in cognitively healthy older adults

AU - Mattsson, Niklas

AU - Insel, Philip

AU - Nosheny, Rachel

AU - Trojanowski, John Q.

AU - Shaw, Leslie M.

AU - Jack, Clifford R Jr.

AU - Tosun, Duygu

AU - Weiner, Michael

PY - 2014/3

Y1 - 2014/3

N2 - Biomarkers associated with Alzheimer's disease (AD)-like brain atrophy in healthy individuals may identify mechanisms involved in early stage AD. Aside from cerebrospinal fluid (CSF) β-amyloid42 (Aβ42) and tau, no studies have tested associations between CSF proteins and AD-like brain atrophy. We studied 90 healthy elders, who underwent lumbar puncture at baseline, and serial magnetic resonance imaging scans for up to 4 years. We tested statistical effects of baseline CSF proteins (N= 70 proteins related to Aβ42-metabolism, microglial activity, and synaptic/neuronal function) on atrophy rates in 7 AD-related regions. Besides the effects of Aβ42 and phosphorylated tau (P-tau) that were seen in several regions, novel CSF proteins were found to have effects in inferior and middle temporal cortex (including apolipoprotein CIII, apolipoprotein D, and apolipoprotein H). Several proteins (including S100β and matrix metalloproteinase-3) had effects that depended on the presence of brain Aβ pathology, as measured by CSF Aβ42. Other proteins (including P-tau and apolipoprotein D) had effects even after adjusting for CSF Aβ42. The statistical effects in this exploratory study were mild and not significant after correction for multiple comparisons, but some of the identified proteins may be associated with brain atrophy in healthy persons. Proteins interacting with CSF Aβ42 may be related to Aβ brain pathology, whereas proteins associated with atrophy even after adjusting for CSF Aβ42 may be related to Aβ-independent mechanisms.

AB - Biomarkers associated with Alzheimer's disease (AD)-like brain atrophy in healthy individuals may identify mechanisms involved in early stage AD. Aside from cerebrospinal fluid (CSF) β-amyloid42 (Aβ42) and tau, no studies have tested associations between CSF proteins and AD-like brain atrophy. We studied 90 healthy elders, who underwent lumbar puncture at baseline, and serial magnetic resonance imaging scans for up to 4 years. We tested statistical effects of baseline CSF proteins (N= 70 proteins related to Aβ42-metabolism, microglial activity, and synaptic/neuronal function) on atrophy rates in 7 AD-related regions. Besides the effects of Aβ42 and phosphorylated tau (P-tau) that were seen in several regions, novel CSF proteins were found to have effects in inferior and middle temporal cortex (including apolipoprotein CIII, apolipoprotein D, and apolipoprotein H). Several proteins (including S100β and matrix metalloproteinase-3) had effects that depended on the presence of brain Aβ pathology, as measured by CSF Aβ42. Other proteins (including P-tau and apolipoprotein D) had effects even after adjusting for CSF Aβ42. The statistical effects in this exploratory study were mild and not significant after correction for multiple comparisons, but some of the identified proteins may be associated with brain atrophy in healthy persons. Proteins interacting with CSF Aβ42 may be related to Aβ brain pathology, whereas proteins associated with atrophy even after adjusting for CSF Aβ42 may be related to Aβ-independent mechanisms.

KW - Alzheimer's disease

KW - Atrophy

KW - Biomarkers

KW - Cerebrospinal fluid

KW - Longitudinal

UR - http://www.scopus.com/inward/record.url?scp=84889600279&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84889600279&partnerID=8YFLogxK

U2 - 10.1016/j.neurobiolaging.2013.08.027

DO - 10.1016/j.neurobiolaging.2013.08.027

M3 - Article

C2 - 24094581

AN - SCOPUS:84889600279

VL - 35

SP - 614

EP - 622

JO - Neurobiology of Aging

JF - Neurobiology of Aging

SN - 0197-4580

IS - 3

ER -